| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 157, Issue 7 2813-2819, Copyright © 1996 by American Association of Immunologists
ARTICLES |
DW Chae, Y Nosaka, TB Strom and W Maslinski
Harvard Medical School, Department of Medicine, Beth Israel Hospital, Boston, MA 02215, USA.
IL-15, a newly described cytokine exerting IL-2-like in vitro activities, binds to and induces proliferation of cells co-expressing IL-15R alpha, IL-2R beta, and IL-2R gamma chains. To study the expression of human IL-15R alpha chains, we have utilized tagged human IL-15 protein and FACS analysis. In contrast to resting cells, mitogen- activated macrophages, NK cells, and CD4+ and CD8+ T cells express IL- 15R alpha chains. Neither IL-2R alpha nor IL-2R beta chains are required for IL-15 binding. Dexamethasone, but not cyclosporine or rapamycin, blocks mitogen-induced IL-15R alpha expression. Dexamethasone-pretreated cells respond to IL-15 poorly, while the response to IL-2 is not affected. Thus, despite structural and functional similarities between IL-2R alpha and IL-15R alpha chains, the activation-triggered mechanisms of induction are different. Since IL-15R alpha chain is necessary and sufficient for IL-15 binding, regulation of IL-15R alpha expression may represent a new target for T cell-directed pharmacologic intervention.
This article has been cited by other articles:
|
|
 |
|
  Y. M. Mueller, D. H. Do, S. R. Altork, C. M. Artlett, E. J. Gracely, C. D. Katsetos, A. Legido, F. Villinger, J. D. Altman, C. R. Brown, et al. IL-15 Treatment during Acute Simian Immunodeficiency Virus (SIV) Infection Increases Viral Set Point and Accelerates Disease Progression despite the Induction of Stronger SIV-Specific CD8+ T Cell Responses J. Immunol., January 1, 2008; 180(1): 350 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Bhorade, A. Yu, W. T. Vigneswaran, C. G. Alex, and E. R. Garrity Elevation of Interleukin-15 Protein Expression in Bronchoalveolar Fluid in Acute Lung Allograft Rejection Chest, February 1, 2007; 131(2): 533 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. B. Strom, L. J. Field, and M. Ruediger Allogeneic Stem Cell-Derived "Repair Unit" Therapy and the Barriers to Clinical Deployment J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1133 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. M. Mueller, V. Makar, P. M. Bojczuk, J. Witek, and P. D. Katsikis IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells Int. Immunol., January 1, 2003; 15(1): 49 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ferrari-Lacraz, X. X. Zheng, Y. S. Kim, Y. Li, W. Maslinski, X. C. Li, and T. B. Strom An Antagonist IL-15/Fc Protein Prevents Costimulation Blockade-Resistant Rejection J. Immunol., September 15, 2001; 167(6): 3478 - 3485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Slavik, D.-G. Lim, S. J. Burakoff, and D. A. Hafler Uncoupling p70s6 Kinase Activation and Proliferation: Rapamycin-Resistant Proliferation of Human CD8+ T Lymphocytes J. Immunol., March 1, 2001; 166(5): 3201 - 3209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. G. Smith, E. M. Bolton, H. Ruchatz, X.-q. Wei, F. Y. Liew, and J. A. Bradley Selective Blockade of IL-15 by Soluble IL-15 Receptor {alpha}-Chain Enhances Cardiac Allograft Survival J. Immunol., September 15, 2000; 165(6): 3444 - 3450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ahmad, E. Sharif-Askari, L. Fawaz, and J. Menezes Innate Immune Response of the Human Host to Exposure with Herpes Simplex Virus Type 1: In Vitro Control of the Virus Infection by Enhanced Natural Killer Activity via Interleukin-15 Induction J. Virol., August 15, 2000; 74(16): 7196 - 7203. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-N. Avice, C. E. Demeure, G. Delespesse, M. Rubio, M. Armant, and M. Sarfati IL-15 Promotes IL-12 Production by Human Monocytes Via T Cell-Dependent Contact and May Contribute to IL-12-Mediated IFN-{gamma} Secretion by CD4+ T Cells in the Absence of TCR Ligation J. Immunol., October 1, 1998; 161(7): 3408 - 3415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. C. Li, P. Roy-Chaudhury, W. W. Hancock, R. Manfro, M. S. Zand, Y. Li, X. X. Zheng, P. W. Nickerson, J. Steiger, T. R. Malek, et al. IL-2 and IL-4 Double Knockout Mice Reject Islet Allografts: A Role for Novel T Cell Growth Factors in Allograft Rejection J. Immunol., July 15, 1998; 161(2): 890 - 896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Dobbeling, R. Dummer, E. Laine, N. Potoczna, J.-Z. Qin, and G. Burg Interleukin-15 Is an Autocrine/Paracrine Viability Factor for Cutaneous T-Cell Lymphoma Cells Blood, July 1, 1998; 92(1): 252 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. S. Kim, W. Maslinski, X. X. Zheng, A. C. Stevens, X. C. Li, G. H. Tesch, V. R. Kelley, and T. B. Strom Targeting the IL-15 Receptor with an Antagonist IL-15 Mutant/Fc{gamma}2a Protein Blocks Delayed-Type Hypersensitivity J. Immunol., June 15, 1998; 160(12): 5742 - 5748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. E. Garcia, D. Jullien, M. Song, K. Uyemura, K. Shuai, C. T. Morita, and R. L. Modlin IL-15 Enhances the Response of Human {gamma}{delta} T Cells to Nonpetide Microbial Antigens J. Immunol., May 1, 1998; 160(9): 4322 - 4329. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
